Os07g0671000 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os07g0671000 antibody; LOC_Os07g47450 antibody; OsJ_25526 antibody; P0470D12.115Flowering-promoting factor 1-like protein 5 antibody; FPF1-like protein 5 antibody
Target Names
Os07g0671000
Uniprot No.

Q&A

Validation of Os07g0671000 Antibody Specificity: Experimental Design

Basic Question: How should researchers validate the specificity of Os07g0671000 Antibody in rice tissues? Answer: Validation requires a multi-step approach combining positive and negative controls. For Os07g0671000, which may encode a stress-related protein (e.g., analogous to Os07g0638300, a 1-Cys peroxiredoxin in submerged rice coleoptiles ), the following methods are recommended:

  • Positive controls: Transfect cells with constructs overexpressing Os07g0671000 to confirm target recognition.

  • Negative controls: Use CRISPR-edited knockout rice lines lacking the gene to exclude non-specific binding .

  • Techniques: Employ orthogonal methods such as western blot (to assess protein presence), immunofluorescence (to localize expression), and co-immunoprecipitation (to identify interacting partners) .

Advanced Question: How can conflicting antibody specificity results across techniques be resolved? Answer: Discrepancies often arise from epitope accessibility or post-translational modifications. To address this:

  • Orthogonal validation: Confirm findings with RNA-seq or mass spectrometry to correlate protein expression with antibody signals .

  • Epitope mapping: Use peptide arrays or competition assays to identify antibody-binding regions and assess interference from phosphorylation/glycosylation .

  • Cross-reactivity testing: Screen against homologous proteins (e.g., Os03g0785900, a glutathione S-transferase ) using dot blots or ELISA .

Cross-Reactivity and Computational Prediction

Basic Question: What steps are required to assess cross-reactivity of Os07g0671000 Antibody with non-target proteins? Answer: Cross-reactivity testing involves systematic screening:

  • Homology analysis: Align Os07g0671000 with sequences in public databases (e.g., UniProt) to identify structurally similar proteins.

  • Experimental validation: Use dot blots or western blots with lysates from tissues expressing these homologs. Include negative controls (e.g., Os06g0225000, a GTP-binding protein ) to confirm specificity.

Advanced Question: Can machine learning predict Os07g0671000 Antibody’s cross-reactivity? Answer: Yes, but requires tailored approaches. Active learning strategies, such as those used in antibody-antigen binding prediction , can prioritize candidate antigens for experimental testing. For example:

  • Feature selection: Use sequence alignment scores, epitope conservation, and 3D structural models to rank potential cross-reactive targets.

  • Iterative testing: Begin with high-probability candidates (e.g., Os07g0638300), then expand to lower-probability ones, reducing experimental costs by up to 35% .

Experimental Controls and Data Interpretation

Basic Question: What controls should be included in western blot experiments using Os07g0671000 Antibody? Answer: Control design is critical for reproducibility. A recommended control framework includes:

Control TypePurposeExample for Os07g0671000
Positive ControlConfirm antibody functionalityLysate from Os07g0671000-overexpressing cells
Negative ControlExclude non-specific bindingLysate from CRISPR-edited knockout rice lines
Loading ControlNormalize protein loadingβ-actin or Ponceau S staining

Advanced Question: How to interpret weak signals in immunoprecipitation assays? Answer: Weak signals may indicate low target abundance or suboptimal antibody-antigen affinity. Mitigation strategies include:

  • Sample enrichment: Use affinity purification tags (e.g., FLAG) fused to the target protein.

  • Antibody optimization: Test antibody concentrations and incubation times; compare with recombinant antibodies, which often show higher affinity .

Role in Stress Responses: Experimental Design

Basic Question: How to design experiments to study Os07g0671000’s role in submergence stress? Answer: Leverage rice submergence models and auxin signaling inhibitors like TIBA :

  • Treatments: Submerge rice seedlings with/without TIBA to mimic submergence stress and auxin inhibition.

  • Sampling: Collect coleoptiles at 0, 24, 48, and 72 hours post-treatment.

  • Analysis: Use RNA-seq to profile Os07g0671000 expression (see Table 1) and immunoblotting to confirm protein levels.

Advanced Question: What transcriptomic insights guide antibody-based studies of Os07g0671000? Answer: From prior studies, genes like Os07g0638300 (1-Cys peroxiredoxin) show stress-responsive expression . For Os07g0671000:

  • Co-expression analysis: Identify genes co-regulated with Os07g0671000 under submergence (e.g., Os11g0453900, ABA-responsive protein ).

  • Pathway mapping: Use tools like KEGG to link Os07g0671000 to redox or stress signaling pathways.

Structural and Functional Insights

Basic Question: How to determine Os07g0671000 Antibody’s epitope? Answer: Epitope mapping is essential for understanding binding specificity:

  • Peptide arrays: Synthesize overlapping peptides spanning Os07g0671000 and test antibody binding via ELISA.

  • Competitive ELISA: Block antibody binding with soluble peptides to identify critical residues.

Advanced Question: Can cryo-EM or X-ray crystallography inform antibody mechanism? Answer: Yes. Structural studies, as demonstrated for measles mAb 77 , reveal how antibodies lock conformational states. For Os07g0671000:

  • Stabilize targets: Engineer Os07g0671000 variants (e.g., with stabilizing mutations) for structural studies.

  • Antibody-target complexes: Capture complexes via cryo-EM to visualize binding sites and conformational changes.

Troubleshooting Antibody Performance

Basic Question: Why might Os07g0671000 Antibody fail in immunohistochemistry? Answer: Common issues include fixation artifacts or epitope masking. Solutions include:

  • Optimize fixation: Test paraformaldehyde vs. methanol fixation.

  • Antigen retrieval: Use heat-induced epitope retrieval (HIER) with citrate buffer.

Advanced Question: How to resolve false positives in antibody-based assays? Answer: False positives often arise from non-specific binding. Mitigation strategies include:

  • Isoform-specific antibodies: Ensure the antibody targets the correct splice variant.

  • Blocking peptides: Pre-incubate primary antibody with excess blocking peptide to confirm specificity.

Computational Integration for Hypothesis Testing

Basic Question: How can active learning improve antibody validation workflows? Answer: Active learning reduces experimental costs by prioritizing high-value tests. For Os07g0671000:

  • Seed dataset: Start with a small set of validated samples.

  • Uncertainty sampling: Select unlabeled samples (e.g., tissues with unknown stress responses) for testing .

Advanced Question: Can transcriptomic data guide antibody validation? Answer: Yes. For example, if Os07g0671000 is upregulated under submergence (as seen for Os07g0638300 ), validate antibody performance in submerged vs. non-submerged tissues. Cross-reference RNA and protein data to confirm concordance.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.